Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.90p
   
  • Change Today:
      0.100p
  • 52 Week High: 6.25p
  • 52 Week Low: 3.50p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,494,153
  • Market Cap: £20.80m

Eden Research product granted temporary approval in Greece

By Josh White

Date: Monday 02 Sep 2024

LONDON (ShareCast) - (Sharecast News) - Sustainable biopesticide developer Eden Research announced on Monday that its Cedroz product has been granted temporary approval in Greece for the 2024 growing season.
The AIM-traded firm said the approval, in accordance with EU Regulation 1107/2009, allowed Cedroz to be used on potatoes to combat wireworms.

Cedroz, distributed in Greece by Eastman Chemical - Eden's commercial partner in several countries - would provide farmers with a new tool to protect potato crops from wireworms.

The pests, which are the larvae of click beetles, cause significant damage to potatoes by creating holes and tunnels, leading to reduced crop quality and yield.

Eden said the increasing prevalence of wireworms had left farmers with limited options, most of which rely on synthetic insecticides.

With an estimated 5,000 to 6,000 hectares of potato fields in Greece affected by wireworms, it said Cedroz presented a substantial commercial opportunity beyond its established role as a nematicide in horticultural crops.

"The granting of this temporary approval indicates that there are no other commercially available, viable alternatives to Cedroz for this particular use," said chief executive officer Sean Smith.

"We have seen in previous trials, and even under a previously granted temporary approval in Italy on wireworms, that the product works well and, as such, we are confident that there is a strong business case for this use."

At 1147 BST, shares in Eden Research were up 6.1% at 4.35p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.90p
Change Today 0.100p
% Change 2.63 %
52 Week High 6.25p
52 Week Low 3.50p
Volume 1,494,153
Shares Issued 533.35m
Market Cap £20.80m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
47.83% below the market average47.83% below the market average47.83% below the market average47.83% below the market average47.83% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Income Not Available
Growth
53.19% above the market average53.19% above the market average53.19% above the market average53.19% above the market average53.19% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Eden Research Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:54 137,044 @ 3.89p
15:54 146,222 @ 3.89p
15:39 240,000 @ 3.90p
13:26 130,000 @ 3.90p
13:26 150,000 @ 3.85p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page